This is CNBC’s 24-hour blog covering all the latest news on the coronavirus outbreak. All times below are in Eastern time. This live blog will be updated throughout the day as the news breaks.
- Global cases: More than 679,000
- Global deaths: At least 31,000
- United States cases: At least 124,600
- United States deaths: At least 2,100
The data above was compiled by Johns Hopkins University.
8:51 am: Relief Therapeutics, NeuroRx get FDA nod to start coronavirus trial
The U.S. Food & Drug Administration has authorized the start of a mid-stage trial by U.S.-Israeli NeuroRx and Relief Therapeutics for the use of Aviptadil to treat Acute Respiratory Distress in coronavirus patients.
The companies said they are recruiting study sites and pharmacies to begin a phase 2 trial. The FDA issued a “study may proceed” letter 24 hours after their investigational new drug application.
Aviptadil is a patented form of Vasoactive Intestinal Polypeptide that has previously shown promise in treating Acute…
